Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Alexander Spira, MD, PhD, FACP, tells us the latest thinking regarding the PD-L1 biomarker

Dr. Spira, Medical Oncologist, Virginia Cancer Specialists, tells us the latest thinking regarding the PD-L1 biomarker in the treatment of lung cancer

Published: 01 April 2019

Recent Videos

video

Nicolas Ferreyros, on the influence of pharmacy benefit managers

Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, considers the influence of pharmacy benefit managers on the lives of cancer ...

video

Ira Klein, MD, MBA, FACP, on embracing value-based oncology care

Dr. Klein, Senior Director, Healthcare Quality Strategy, Strategic Customer Group, Johnson & Johnson Health Care Systems Inc., on embracing value-based ...

video

Nicolas Ferreyros, on what oncologists should know about their federal policymakers

Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, offers opinion on what medical oncologists and practice administrators should know about ...

video

Ira Klein, MD, MBA, FACP, provides perspective on the rising cost of cancer drugs

Dr. Klein, Senior Director, Healthcare Quality Strategy, Strategic Customer Group, Johnson & Johnson Health Care Systems Inc., provides perspective on ...

video

Nicolas Ferreyros, explains why oncologists should communicate with their local representatives

Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, explains why oncologists should communicate with their local representatives

video

Ira Klein, MD, MBA, FACP, on the role of value in cancer drug development

Dr. Klein, Senior Director, Healthcare Quality Strategy, Strategic Customer Group, Johnson & Johnson Health Care Systems Inc., how value plays ...

video

Melissa Johnson, MD, shares her thoughts on biomarker development in NSCLC

Dr. Johnson, Associate Director, Lung Cancer Research Program, Sarah Cannon Research Institute, shares her thoughts on biomarker development in managing ...

video

Melissa Johnson, MD, speculates on exciting developments in the treatment of NSCLC

Dr. Johnson, Associate Director, Lung Cancer Research Program, Sarah Cannon Research Institute, tells us about some of the exciting new ...

video

Anshu Jain, MD, tells us what physicians & payers should know about proton therapy

Dr. Jain, Radiation Oncologist, COA Board Member, tells us what physicians and payers should know about proton therapy

video

Melissa Johnson, MD, on the updated NCCN guidelines in regards to PD-L1 testing

Dr. Johnson, Associate Director, Lung Cancer Research Program, Sarah Cannon Research Institute, elaborates on the recent updates to NCCN guidelines ...

Related Videos

video-image

Ira Klein, MD, MBA, FACP, on the role of value in cancer drug development

video-image

Nicolas Ferreyros, explains why oncologists should communicate with their local representatives

video-image

Ira Klein, MD, MBA, FACP, provides perspective on the rising cost of cancer drugs

video-image

Nicolas Ferreyros, on what oncologists should know about their federal policymakers

video-image

Ira Klein, MD, MBA, FACP, on embracing value-based oncology care

video-image

Nicolas Ferreyros, on the influence of pharmacy benefit managers

video-image

Melissa Johnson, MD, shares her thoughts on biomarker development in NSCLC

video-image

Lakshmi Aggarwal, MD, offers opinion on the evolving landscape of oncology

video-image

Anshu Jain, MD, on the current controversy regarding proton therapy in cancer care

video-image

Lucio Gordan, MD, shares how the shift in site of care is impacting community oncology

video-image

Melissa Johnson, MD, on the updated NCCN guidelines in regards to PD-L1 testing

video-image

Lakshmi Aggarwal, MD, considers the role of politics in oncology

video-image

Anshu Jain, MD, tells us what physicians & payers should know about proton therapy

video-image

Jesse Dresser on the trends he is observing between payers and dispensing practices & pharmacies

video-image

Matthew Hall, MD, on the difference between photon therapy & proton therapy

video-image

Melissa Johnson, MD, speculates on exciting developments in the treatment of NSCLC

video-image

Kathy Gaughran explains how Healthcare Success is helping community oncologists

video-image

Lakshmi Aggarwal, MD, explains why transparency is necessary in the healthcare system

video-image

Jesse Dresser considers the challenges for dispensing oncology practices regarding payer networks

video-image

Matthew Hall, MD, considers whether the application of proton therapy is growing